The Unlikely Bet: What's Behind MaxCyte's Rising Stock Appeal MaxCyte, Inc. , a cell engineering company, has been making waves in the market despite its recent downturn.
In Minot Light Capital Partners' latest quarterly investor letter, MaxCyte emerged as one of the fund's top five holdings, with the investment firm touting its potential to rebound.
Minot Light's confidence in MaxCyte is based on the idea that the company's valuation is so low it's bound to rebound at some point.